ConductScience.org, home

Paper8201580

New respiratory therapies in cystic fibrosis.

Stableforth DE. J R Soc Med, 1994. Cited by 3 papers, by iCite.

Cite this record

ConductScience Library. New respiratory therapies in cystic fibrosis. Papers, record 8201580. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/8201580

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
New respiratory therapies in cystic fibrosis.
PubMed
Journal
J R Soc Med
PubMed
Year
1994
PubMed
Publication types
Journal Article, Review
PubMed
Citations, by iCite
3
iCite
Relative citation ratio, by iCite
0.08
iCite
Revised in PubMed
2020-06-11
PubMed

Authors1

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Stableforth DED E

Source PubMed

Download CSV of authors

Topics8

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Cystic FibrosisMajor topic
Anti-Bacterial Agents
Anti-Inflammatory Agents
Genetic Therapy
Humans
Lung Transplantation
Respiratory Therapy
Tissue and Organ Procurement

Source PubMed

Download CSV of topics

References45

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
1486968Evaluation of the forced expiration technique as an adjunct to postural drainage in treatment of cystic fibrosis.Br Med J1979https://conductscience.org/library/papers/486968PubMed
28100928Efficacy and safety of short-term administration of aerosolised recombinant human DNase I in adults with stable stage cystic fibrosis.Lancet1993https://conductscience.org/library/papers/8100928PubMed
37039345Amiloride: a molecular probe of sodium transport in tissues and cells.Am J Physiol1982https://conductscience.org/library/papers/7039345PubMed
42863676Alternate-day prednisone reduces morbidity and improves pulmonary function in cystic fibrosis.Lancet1985https://conductscience.org/library/papers/2863676PubMed
52425436Altered regulation of airway epithelial cell chloride channels in cystic fibrosis.Science1986https://conductscience.org/library/papers/2425436PubMed
63524474Face mask physiotherapy in cystic fibrosis.Arch Dis Child1986https://conductscience.org/library/papers/3524474PubMed
73777691Deposition, clearance, and effects of aerosolized amiloride in sheep airways.Am Rev Respir Dis1986https://conductscience.org/library/papers/3777691PubMed
83479420The efficacy and safety of ciprofloxacin and ofloxacin in chronic Pseudomonas aeruginosa infection in cystic fibrosis.J Antimicrob Chemother1987https://conductscience.org/library/papers/3479420PubMed
92451291Amiloride selectively blocks the low threshold (T) calcium channel.Science1988https://conductscience.org/library/papers/2451291PubMed
102899664Heart-lung transplantation for cystic fibrosis.Lancet1988https://conductscience.org/library/papers/2899664PubMed
112930207Inhibition of allergic contact dermatitis and ultraviolet radiation-induced tissue swelling in the mouse by topical amiloride.Arch Dermatol1989https://conductscience.org/library/papers/2930207PubMed
122475911Identification of the cystic fibrosis gene: cloning and characterization of complementary DNA.Science1989https://conductscience.org/library/papers/2475911PubMed
132570460Identification of the cystic fibrosis gene: genetic analysis.Science1989https://conductscience.org/library/papers/2570460PubMed
142310093Acute and long-term amiloride inhalation in cystic fibrosis lung disease. A rational approach to cystic fibrosis therapy.Am Rev Respir Dis1990https://conductscience.org/library/papers/2310093PubMed
151697059Pseudomonas hyperimmune globulin passive immunotherapy for pulmonary exacerbations in cystic fibrosis.Pediatr Pulmonol1990https://conductscience.org/library/papers/1697059PubMed
162251263Recombinant human DNase I reduces the viscosity of cystic fibrosis sputum.Proc Natl Acad Sci U S A1990https://conductscience.org/library/papers/2251263PubMed
171671425Aerosol alpha 1-antitrypsin treatment for cystic fibrosis.Lancet1991https://conductscience.org/library/papers/1671425PubMed
182040934Ibuprofen in children with cystic fibrosis: pharmacokinetics and adverse effects.J Pediatr1991https://conductscience.org/library/papers/2040934PubMed
191856144Once daily dosing of aminoglycoside: one step forward.J Antimicrob Chemother1991https://conductscience.org/library/papers/1856144PubMed
201857389Activation by extracellular nucleotides of chloride secretion in the airway epithelia of patients with cystic fibrosis.N Engl J Med1991https://conductscience.org/library/papers/1857389PubMed

See all 45 referencesDownload CSV of references

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Cited by
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/8201580

GET https://conductscience.org/api/papers/v1/8201580/references?page=2